Seres Therapeutics
MCRB
MCRB
152 hedge funds and large institutions have $2.12B invested in Seres Therapeutics in 2020 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 48 increasing their positions, 36 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.16% less ownership
Funds ownership: 4.91% → 4.74% (-0.16%)
13% less capital invested
Capital invested by funds: $2.42B → $2.12B (-$303M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
152
Holding in Top 10
2
Calls
$17.7M
Puts
$6.75M
Top Buyers
| 1 | +$66.2M | |
| 2 | +$35.5M | |
| 3 | +$31.9M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$24.7M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$17.9M |
Top Sellers
| 1 | -$169M | |
| 2 | -$134M | |
| 3 | -$6.76M | |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$3.78M |
| 5 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$3.44M |